This is in stark contrast to the reduced tumor burden observed in models of Cre/lox-mediated Myc ablation in tumor cells, including our own observations in Tff1CreERT2;Mycfl/fl;Gp130F/F Myc-depleted gastric adenomas. This evidence concerns the gene MYC and neoplasm.